Covaxin has been given approval in clinical trial mode

|
Wednesday, January 6, 2021
covaxin has been given approval in clinical trial mode

As soon as DCGI gave its nod to Bharat Biotech’s Covaxin, people raised concerns about its efficacy as the vaccine has been cleared on the basis of its safety and immunogenicity data. Its efficacy data has not been published yet. 

To clear the air around the approval of the vaccine, Dr Balram Bhargava, chief of Indian Council of Medical Research (ICMR), said on Tuesday that Bharat Biotech’s Covid-19 vaccine has been cleared in the clinical trial mode, which means consent of participants has to be taken. 

Explaining the process followed in granting approval to Oxford University-AstraZeneca’s Covashield and ICMR-Bharat Biotech’s developed Covaxin, Bhargava said, “The existing pandemic situation, high mortality, available science and lack of definitive treatments were considered by the subject expert committee (SEC) on Covid-19 of CDSCO for granting accelerated approval to these vaccines, and that is in our legal provision.”

The Drugs Controller General of India (DCGI) approved two vaccines for restricted emergency use in the country. Some doctors, scientists, and political leaders have raised concern over the absence of Phase-III trial data on Bharat Biotech’s Covaxin. 

Quoting a  special clause, Dr Bhargav said, “The Clinical Trial Rule, 2019, provides for considering phase two results to guide approval. Now the SEC guides the DCGI in the process of decision making for restricted use under emergency situation. Now we have two vaccines,” Bhargava said.

Union health secretary Rajesh Bhushan also said that the ministry is prepared to roll out Covid-19 vaccine within 10 days. 

0 Comment

Every vulnerable person around the world should be protected from COVID-19

In a candid conversation, she talks about COVAX Facility, the initiative to provide equitable access to COVID vaccine and how it will help the world end the pandemic....

A headband to cure Alzheimer's 

The olfactory function can play a key role in regaining consciousness after brain injuries and by stimulating it, one can prevent Alzheimer's Disease. ....

SARS-CoV-2 will continue to evolve

SARS-CoV-2 will continue to evolve, and a gradual change in disease severity and transmissibility should be anticipated, but there is currently no e....

This extraordinary virtual meeting for the Strategic Advisory Group of Experts on Immunization (SAGE) will be held on Tuesday 05 January 2021 to propose reco...